For the Inventor, By the Inventor

Enter assignee name

Cadila Healthcare Limited

USPTO Granted Patents = 130

CIPO Patents = 5

EPO Patents = 57

Trademarks = 1

Forward Citations = 330

Loading Chart...

Loading Chart...

164 inventors (with patents filed for the assignee):

Braj Bhushan Lohray (24 out of 24 patents)

Vidya Bhushan Lohray (23 out of 23 patents)

Pankaj Ramanbhai Patel (22 out of 23 patents)

4. Shriprakash Dhar Dwivedi (18 out of 18 patents)

5. Bipin Pandey (18 out of 18 patents)

6. Mukul R Jain (13 out of 16 patents)

7. Kumar Kamlesh Singh (12 out of 15 patents)

8. Brij Khera (9 out of 9 patents)

9. Shafiq Sheikh (9 out of 9 patents)

10. Mayank Ghanshyambhai Dave (9 out of 9 patents)

11. Sanjeev Kumar Mendiratta (9 out of 9 patents)

12. Ranjit C Desai (8 out of 8 patents)

13. Sunilendu Bhushan Roy (8 out of 8 patents)

14. Jay Shantilal Kothari (8 out of 8 patents)

15. Ashok Prasad (8 out of 8 patents)

Core Competencies:

Primary Biliary Cholangitis

Peptide Vaccines

Grapiprant Preparation

Sulfoximine Compounds

Injectable Solutions

Quinolone Compounds

Hypolipidemic Agents

Pharmaceutical Formulations

Monoclonal Antibodies

Topical Compositions

Heterocyclic Compounds

Janus Kinase Inhibitors

130 patents: Sort by Forward Citations

1. 11433050 - Treatment for primary biliary cholangitis (2022-09-06),

2. 11325945 - Peptide based PCSK9 vaccine (2022-05-10),

3. 11254675 - Process for preparation of grapiprant (2022-02-22),

4. 11236045 - Substituted sulfoximine compounds (2022-02-01),

5. 11110073 - Storage stable aqueous injectable solution comprising diclofenac (2021-09-07),

6. 10934269 - Process for preparation of apalutamide (2021-03-02),

7. 10925871 - Pharmaceutical compositions of sitagliptin (2021-02-23),

8. 10899713 - Process for the preparation of quinolone based compounds (2021-01-26),

9. 10815227 - Processes for the preparation of filgotinib (2020-10-27),

10. 10807965 - Process for preparation of apalutamide (2020-10-20),

11. 10550150 - Short-chain peptides as Kappa (κ) opioid receptors (KOR) agonist (2020-02-04),

12. 10435363 - Process for preparation of pyrroles having hypolipidemic hypocholesteremic activities (2019-10-08),

13. 10414741 - Amorphous vortioxetine and salts thereof (2019-09-17),

14. 10385017 - Pyrrole compound, compositions and process for preparation thereof (2019-08-20),

15. 10358440 - Process for the preparation of brexpiprazole and intermediates thereof (2019-07-23),

Cadila Healthcare Limited, established in 1952, is one of the largest pharmaceutical companies in India. It specializes in the development, manufacturing, and marketing of a wide range of healthcare products including pharmaceuticals, diagnostics, biotechnology products, herbal medicines, and animal healthcare products. With a strong focus on research and innovation, Cadila Healthcare strives to provide quality and affordable healthcare solutions to people worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

130 Patents

#1 in Gujarat

#16 in India

#6,006 in the World

Cadila Healthcare Limited

Forward Citations = 330

164 inventors:

Braj Bhushan Lohray (24 out of 24 patents)

Vidya Bhushan Lohray (23 out of 23 patents)

Pankaj Ramanbhai Patel (22 out of 23 patents)

4. Shriprakash Dhar Dwivedi (18 out of 18 patents)

5. Bipin Pandey (18 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…